Cargando…

Lipoproteins as Drug Carriers for Cyclosporine A: Optimization of the Entrapment

Lipoproteins are natural nanostructures responsible for the transport of cholesterol and other lipids in the blood. They are characterized by having a lipophilic core surrounded by an amphiphilic shell composed of phospholipids, cholesterol and one or more apolipoproteins. Being endogenous carriers...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel-Mottaleb, Mona M. A., Boi, Lorenza, Barra, Marina, Colin, Julie, Berni, Luisa, Béduneau, Arnaud, Moulari, Brice, Pellequer, Yann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918909/
https://www.ncbi.nlm.nih.gov/pubmed/36770166
http://dx.doi.org/10.3390/ma16031156
_version_ 1784886692643078144
author Abdel-Mottaleb, Mona M. A.
Boi, Lorenza
Barra, Marina
Colin, Julie
Berni, Luisa
Béduneau, Arnaud
Moulari, Brice
Pellequer, Yann
author_facet Abdel-Mottaleb, Mona M. A.
Boi, Lorenza
Barra, Marina
Colin, Julie
Berni, Luisa
Béduneau, Arnaud
Moulari, Brice
Pellequer, Yann
author_sort Abdel-Mottaleb, Mona M. A.
collection PubMed
description Lipoproteins are natural nanostructures responsible for the transport of cholesterol and other lipids in the blood. They are characterized by having a lipophilic core surrounded by an amphiphilic shell composed of phospholipids, cholesterol and one or more apolipoproteins. Being endogenous carriers makes them suitable for drug delivery purposes. Here, we investigate the effect of lipoproteins’ intricate composition on the entrapment efficiency of a model drug “Cyclosporine A” into the different types of lipoproteins, namely, HDL, LDL and VLDL. It was observed that the protein content of the lipoproteins had the highest effect on the entrapment of the drug with a correlation coefficient of 0.80, 0.81 and 0.96 for HDL, LDL and VLDL respectively. This was even confirmed by the effect of plasma on the association rate of lipoproteins and the drug. The second effective factor is the cholesterol concentration, while triglycerides and phospholipids had a negligible effect.
format Online
Article
Text
id pubmed-9918909
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99189092023-02-12 Lipoproteins as Drug Carriers for Cyclosporine A: Optimization of the Entrapment Abdel-Mottaleb, Mona M. A. Boi, Lorenza Barra, Marina Colin, Julie Berni, Luisa Béduneau, Arnaud Moulari, Brice Pellequer, Yann Materials (Basel) Communication Lipoproteins are natural nanostructures responsible for the transport of cholesterol and other lipids in the blood. They are characterized by having a lipophilic core surrounded by an amphiphilic shell composed of phospholipids, cholesterol and one or more apolipoproteins. Being endogenous carriers makes them suitable for drug delivery purposes. Here, we investigate the effect of lipoproteins’ intricate composition on the entrapment efficiency of a model drug “Cyclosporine A” into the different types of lipoproteins, namely, HDL, LDL and VLDL. It was observed that the protein content of the lipoproteins had the highest effect on the entrapment of the drug with a correlation coefficient of 0.80, 0.81 and 0.96 for HDL, LDL and VLDL respectively. This was even confirmed by the effect of plasma on the association rate of lipoproteins and the drug. The second effective factor is the cholesterol concentration, while triglycerides and phospholipids had a negligible effect. MDPI 2023-01-29 /pmc/articles/PMC9918909/ /pubmed/36770166 http://dx.doi.org/10.3390/ma16031156 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Abdel-Mottaleb, Mona M. A.
Boi, Lorenza
Barra, Marina
Colin, Julie
Berni, Luisa
Béduneau, Arnaud
Moulari, Brice
Pellequer, Yann
Lipoproteins as Drug Carriers for Cyclosporine A: Optimization of the Entrapment
title Lipoproteins as Drug Carriers for Cyclosporine A: Optimization of the Entrapment
title_full Lipoproteins as Drug Carriers for Cyclosporine A: Optimization of the Entrapment
title_fullStr Lipoproteins as Drug Carriers for Cyclosporine A: Optimization of the Entrapment
title_full_unstemmed Lipoproteins as Drug Carriers for Cyclosporine A: Optimization of the Entrapment
title_short Lipoproteins as Drug Carriers for Cyclosporine A: Optimization of the Entrapment
title_sort lipoproteins as drug carriers for cyclosporine a: optimization of the entrapment
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918909/
https://www.ncbi.nlm.nih.gov/pubmed/36770166
http://dx.doi.org/10.3390/ma16031156
work_keys_str_mv AT abdelmottalebmonama lipoproteinsasdrugcarriersforcyclosporineaoptimizationoftheentrapment
AT boilorenza lipoproteinsasdrugcarriersforcyclosporineaoptimizationoftheentrapment
AT barramarina lipoproteinsasdrugcarriersforcyclosporineaoptimizationoftheentrapment
AT colinjulie lipoproteinsasdrugcarriersforcyclosporineaoptimizationoftheentrapment
AT berniluisa lipoproteinsasdrugcarriersforcyclosporineaoptimizationoftheentrapment
AT beduneauarnaud lipoproteinsasdrugcarriersforcyclosporineaoptimizationoftheentrapment
AT moularibrice lipoproteinsasdrugcarriersforcyclosporineaoptimizationoftheentrapment
AT pellequeryann lipoproteinsasdrugcarriersforcyclosporineaoptimizationoftheentrapment